348 related articles for article (PubMed ID: 9349513)
1. A more accurate measure of the false-negative rate of Papanicolaou smear screening is obtained by determining the false-negative rate of the rescreening process.
Renshaw AA; DiNisco SA; Minter LJ; Cibas ES
Cancer; 1997 Oct; 81(5):272-6. PubMed ID: 9349513
[TBL] [Abstract][Full Text] [Related]
2. Analysis of error in calculating the false-negative rate in the interpretation of cervicovaginal smears: the need to review abnormal cases.
Renshaw AA
Cancer; 1997 Oct; 81(5):264-71. PubMed ID: 9349512
[TBL] [Abstract][Full Text] [Related]
3. One hundred percent thorough quality control rescreening of liquid-based monolayers in cervicovaginal cytopathology.
Rowe LR; Marshall CJ; Bentz JS
Cancer; 2002 Dec; 96(6):325-9. PubMed ID: 12478679
[TBL] [Abstract][Full Text] [Related]
4. Rapid prescreening of Papanicolaou smears: a practical and efficient quality control strategy.
Djemli A; Khetani K; Auger M
Cancer; 2006 Feb; 108(1):21-6. PubMed ID: 16302251
[TBL] [Abstract][Full Text] [Related]
5. False negative rate of cervical cytologic smear screening as determined by rapid rescreening.
Renshaw AA; Bellerose B; DiNisco SA; Minter LJ; Lee KR
Acta Cytol; 1999; 43(3):344-50. PubMed ID: 10349360
[TBL] [Abstract][Full Text] [Related]
6. Rescreening in gynecologic cytology. Rescreening of 3762 previous cases for current high-grade squamous intraepithelial lesions and carcinoma--a College of American Pathologists Q-Probes study of 312 institutions.
Jones BA
Arch Pathol Lab Med; 1995 Dec; 119(12):1097-103. PubMed ID: 7503656
[TBL] [Abstract][Full Text] [Related]
7. Interpretive yields of screening Pap tests and diagnostic Pap tests.
Stelow EB; Gulbahce HE; Kjeldahl K; Oprea GM; Savik K; Pambuccian SE
Diagn Cytopathol; 2004 Dec; 31(6):427-9. PubMed ID: 15540184
[TBL] [Abstract][Full Text] [Related]
8. [The PAPNET system in the rescreening of negative cervical/vaginal smears. A study from the Imola cytology laboratory].
Ghidoni D; Fabbris E; Folicaldi S; Amadori A; Medri M; Bucchi L; Bondi A
Pathologica; 1998 Aug; 90(4):357-63. PubMed ID: 9793395
[TBL] [Abstract][Full Text] [Related]
9. A practical problem with calculating the false-negative rate of Papanicolaou smear interpretation by rescreening negative cases alone.
Renshaw AA
Cancer; 1999 Dec; 87(6):351-3. PubMed ID: 10603188
[TBL] [Abstract][Full Text] [Related]
10. Quality and liability issues with the Papanicolaou smear: the problem of definition of errors and false-negative smears.
Davey DD
Arch Pathol Lab Med; 1997 Mar; 121(3):267-9. PubMed ID: 9111115
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of 100% rapid rescreening of negative cervical smears as a quality assurance measure.
Manrique EJ; Amaral RG; Souza NL; Tavares SB; Albuquerque ZB; Zeferino LC
Cytopathology; 2006 Jun; 17(3):116-20. PubMed ID: 16719853
[TBL] [Abstract][Full Text] [Related]
12. The human false-negative rate of rescreening Pap tests. Measured in a two-arm prospective clinical trial.
Renshaw AA; Lezon KM; Wilbur DC
Cancer; 2001 Apr; 93(2):106-10. PubMed ID: 11309775
[TBL] [Abstract][Full Text] [Related]
13. Low proportion of false-negative smears in the Finnish program for cervical cancer screening.
Lönnberg S; Anttila A; Kotaniemi-Talonen L; Kujari H; Melkko J; Granroth G; Vornanen M; Pietiläinen T; Sankila A; Arola J; Luostarinen T; Nieminen P
Cancer Epidemiol Biomarkers Prev; 2010 Feb; 19(2):381-7. PubMed ID: 20142239
[TBL] [Abstract][Full Text] [Related]
14. High-grade squamous intraepithelial lesions and invasive carcinoma following the report of three negative Papanicolaou smears: screening failures or rapid progression?
Sherman ME; Kelly D
Mod Pathol; 1992 May; 5(3):337-42. PubMed ID: 1495939
[TBL] [Abstract][Full Text] [Related]
15. [Analysis of the intralaboratory diagnostic variability in the Imola cervical screening program].
Fabbris E; Bucchi L; Folicaldi S; Amadori A; Ghidoni D; Medri M; Bondi A
Pathologica; 1998 Apr; 90(2):127-32. PubMed ID: 9619055
[TBL] [Abstract][Full Text] [Related]
16. Atypical squamous cells of undetermined significance: a comparative review of original and automated rescreen diagnosis of cervicovaginal smears with long term follow-up.
Stastny JF; Remmers RE; London WB; Pedigo MA; Cahill LA; Ryan M; Frable WJ
Cancer; 1997 Dec; 81(6):348-53. PubMed ID: 9438460
[TBL] [Abstract][Full Text] [Related]
17. ThinPrep Papanicolaou testing to reduce false-negative cervical cytology.
Linder J; Zahniser D
Arch Pathol Lab Med; 1998 Feb; 122(2):139-44. PubMed ID: 9499356
[TBL] [Abstract][Full Text] [Related]
18. Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer.
Nieminen P; Vuorma S; Viikki M; Hakama M; Anttila A
BJOG; 2004 Aug; 111(8):842-8. PubMed ID: 15270934
[TBL] [Abstract][Full Text] [Related]
19. Follow-up of Papanicolaou smears diagnosed as atypical squamous cells of undetermined significance.
Howell LP; Davis RL
Diagn Cytopathol; 1996 Feb; 14(1):20-4. PubMed ID: 8834072
[TBL] [Abstract][Full Text] [Related]
20. Blinded review of papanicolaou smears.
Frable WJ
Cancer; 2004 Jun; 102(3):133-5. PubMed ID: 15211470
[No Abstract] [Full Text] [Related]
[Next] [New Search]
